Objectives-To evaluate renal parenchymal elasticity with acoustic radiation force impulse imaging in pediatric patients with chronic kidney disease (CKD) and compare with healthy volunteers.
C hronic kidney disease (CKD) can be diagnosed through assessment of the glomerular filtration rate (GFR), accompanied by anomalies in blood and urine coursing below 60 mL/min for 3 months, and may or may not be accompanied by imaging tests and a kidney biopsy. 1 In the pediatric population, the main reasons for CKD are vesicoureteral reflux, congenital abnormalities of kidney and urinary tract, steroid-resistant nephrotic syndrome, chronic glomerulonephritis (eg, lupus nephritis, Alport syndrome), and renal ciliopathies. Less common causes of CKD in children include thrombotic microangiopathies (especially atypical hemolytic uremic syndrome), nephrolithiasis/nephrocalcinosis, Wilms tumor, infectious and interstitial diseases, and others. 2 The common result of all of these pathological processes is renal fibrosis development, which causes loss of functional nephrons. 1 At this point, the treatment of renal fibrosis is a perfect target for the management of CKD, and early diagnosis and effective treatment strategy is very important. Although a renal biopsy is the standard procedure for diagnosing renal fibrosis, for purposes of differentiating between normal kidney and abnormal kidney and determining the stages of the disease, this invasive process may cause complications such as hematoma, macroscopic hematuria, arteriovenous fistula, and infection. 3 In addition, another disadvantage of the biopsy procedure is the fact that it requires sedation in pediatric patients. Kidney size and parenchyma thickness are measured ultrasonographically, and measurements such as resistive index have low sensitivity and specificity in the diagnosis of CKD. 4 Acoustic radiation force imaging (ARFI) is a recently established, noninvasive, inexpensive, safe, and convenient ultrasound-based diagnostic technique for evaluating the elastic properties of tissues. 5, 6 In this modality, instead of outer compression, a short-term (0.03-0.4 ms), high-powered (2.67-MHz frequency) acoustic compressive radiation force is applied on the tissue within a region of interest (ROI) through ultrasound transducers. This force causes small displacements in the tissue (1-10 lm). On the horizontal plane, these translocations are called "shear wave." The speed of progression of these waves in the tissue can be measured with high-speed, advanced ultrasound sampling techniques. In acoustic radiation force impulse imaging, shear wave velocity (SW) is given as SW m/s. The classic parameter to describe tissue stiffness is Young's elastic modulus, which is directly proportional to the square of the SW. Shear wave velocity is directly proportional to the stiffness of the tissue (m/s). The force applied on the tissue is constant, and the only variable is the SW. Thus, the velocity values obtained show the objective tissue elasticity values. Although the clinical use of ARFI and its contributions to diagnosis are still under investigation, there are studies that have reported its contributions to diagnosis in diseases of the breast, thyroid, liver, pancreas, kidney, testicles, and prostate. 7, 8 Recent studies have found a high correlation between hepatic fibrosis and ARFI measurements, and these studies have been adapted to kidneys, too. A few available studies in the literature have assessed renal fibrosis in adult chronic kidney disease patients and renal transplant patients, and they have given promising results. 9, 10 The objective of this study is to research the efficacy of shear wave elastography in differentiating and staging chronic kidney disease in pediatric kidneys. To the best of our knowledge, this study is the first one to research the efficiency of ARFI in pediatric patients with CKD.
Materials and Methods
Patients Fifty-one kidneys of 30 patients (age range 5-17 years: mean age 6 standard deviation (SD), 13.82 6 3.29 years; 15 females; 15 males) with pathologically diagnosed CKD were followed, and 76 kidneys of 38 healthy volunteers (age range 7-17 years: mean age 6 SD, 12.88 6 3.2 years; 25 females; 13 males) were included in the study. The patients had a history of CKD between 6 months and 7 years. All of the patients underwent clinical examination, laboratory tests and renal biopsy, and all of the patients met the diagnostic criteria of CKD. The diagnosis of CKD was on the basis of kidney damage or GFR, and was classified into stages as given in Table 1 . The exclusion criteria were the presence of calculi, cyst, mass, congenital variation, and hydronephrosis or kidney atrophy. In nine of the CKD patients who did not meet these criteria, one-sided measurement was made. Our hospital's ethical board approved of this prospective study in accordance with the 1975 Helsinki Note: Chronic kidney disease is defined as either kidney damage or GFR less than 60 mL/min/1.73 m 2 for 3 or more months. Kidney damage is defined as pathologic abnormalities or markers of damage, including abnormalities in blood or urine tests or imaging studies. In our study, CKD was defined as estimated GFR < 60 mL/min/1.73 m 2 or albuminuria. Albuminuria was defied as a urinary albumin.
Declaration, and written consent was taken from all patients. The patients' body mass index, age, height, and weight values were recorded. The control group was chosen from among individuals who had no kidney disease with normal creatinine, GFR values, and urine test by taking age and gender distribution into consideration. All of the volunteers in the control group had normal imaging findings by renal ultrasonography.
Classification of Study Population
The patients evaluated through ARFI in this study were classified in three groups: 
Acoustic Radiation Force Impulse Elastography
All ARFI elastography examinations were made using a Virtual Touch tissue quantification application on an Acuson S2000 ultrasound system (Siemens Medical Solutions, Mountain View, CA) equipped with ARFI function. The value of 1.6 was used as the mechanical index, and a curved array transducer (6C1HD; 4 MHz) of the Acuson S2000 US system was used. Tissue harmonic imaging was used to optimize the ultrasound imaging. The ARFI measurements were made by a radiologist with 4 years of elastography experience, who was blind to the patients' CKD stages. To test the interobserver agreement, 23 of the patients were chosen randomly and evaluated by another radiologist with 2 years of ultrasound elastography experience. When investigating the interobserver agreement, the participants were examined on the same day by both observers. The ARFI elastography measurements were made of all patients in the prone position following micturition. A standard ROI cursor was placed on the renal cortex of the renal midportion, parallel to the main axis of the renal pyramids, with just enough pressure to obtain the gray scale image, with breath-holding to minimize breathing artifacts (Figure 1) . Renal medulla, sinus, and the surrounding tissues were carefully kept out of the sample size. Renal medulla, sinus, and the surrounding tissues were carefully kept outside of the sample size. Measurements were not taken from kidneys, which were not differentiated from the neighboring fatty tissue because of being agenetic or having a grade-4 echogenity increase. We planned to take six valid measurements from each kidney of the patients, and the mean value of these six measurements was expressed in meters per second (m/ s) by using a harmonic mean. The mean SW value of two kidneys was used in the statics with measurements from two kidneys. If only one side was used for measurements in the patients for reasons of, for example, agenesis or atrophy, that kidney's SW value used for statics. In faulty measurements, the value "x.xx" was seen on the screen and the measurement was repeated until a valid value was obtained. This ARFI protocol was formed to minimize the force applied on the transducer and sampling errors caused by noncortical tissues and the structural anisotropy of the kidney. 
Statistical Analyses
Statistical analyses were performed with SPSS 18.0 for Windows. Data were presented as within the mean 6 SD and as the median (min-max). The Shapiro-Wilk test was used to analyze the normal distribution assumption of the quantitative outcomes. To compare two independent groups, we used the student's t-test for normal data and the Mann-Whitney U test for abnormal data. A receiver operating characteristic (ROC) curve was used to illustrate and evaluate the diagnostic performance of ARFI. The area under the ROC curve (AUC) was evaluated as the measure of a diagnostic test's discriminatory power. Confidence intervals can be computed for AUC. The interclass correlation coefficient (ICC) was performed to quantify the agreement between measurements. Agreement was indicative of poor (ICC < 0.40), fair to good (ICC 5 0.40-0.75), or excellent (ICC > 0.75). Because of the relatively low number of subjects, to compare the interobserver agreement, the mean and SD of the difference between the observed values were calculated and the results plotted in a Bland-Altman graph. In this article, the sensitivity, specificity, positive predictive values, and negative predictive values were evaluated. A P value less than .05 was considered as statistically significant. Table 2 summarizes the CKD etiologies of the patients, and Table 3 summarizes both groups' comparative demographic features and ARFI SW values. In all stages of the disease, the kidney SW values of CKD patients were found to be statistically significantly low when compared with the kidney ARFI SW values of healthy volunteers ( Figure 2 ) (P < .001). When the SW cut-off value between healthy volunteers and patients was taken as 1.81, the sensitivity, specificity, positive predictive values, and negative predictive values were 76.5, 92.1, 81.3, and 89.7%, respectively (AUC 5 0.870 [95% confidence interval (CI): 0.750-0.990]; P < .001) ( Figure 3A ). In patients with CDK, no statistically significant difference was found in stages 1, 2, 3, and 4 with the exception of stage 5. Accordingly, when CKD patients were grouped and assessed as "predialysis" and "dialysis" patients, ARFI SW values were found to be statistically significantly low in the dialysis patient group (P 5 .001). With a 1.32 cut-off value, the sensitivity, specificity, positive predictive values, and negative predictive values of ARFI in differentiating predialysis and dialysis patients were 76.9, 88.2, 83.3, and 83.3%, respectively (AUC 5 0.846 [95% CI: 0.691-0.1001]; P 5 .001) ( Figure 3B ). The interobserver agreement, expressed as ICC, was 0.65 (95% CI: 0.34 to 0.83; P < .001). This indicated that the SW measurements had fair to good reproducibility. Interobserver variability is given as a Bland-Altman plot in Figure 4 .
Results

Discussion
The main pathological change in CKD is the replacement of normal renal units by a great number of fibroblasts and myofibroblasts and the resulting glomerulosclerosis and tubulointerstitial fibrosis, causing the loss of renal functions. Pathological changes in renal fibrosis change gradually from mild to severe. 9 This situation can be prevented or delayed with early diagnosis and medication; however, in severe cases, it can become irreversible. Thus, the early diagnosis of renal fibrosis is quite important for the treatment of the disease. Currently, the clinical diagnosis of the disease depends on a renal biopsy. However, a needle biopsy is an invasive method with different degrees of risks as well as requiring sedation in most pediatric patients. 5 Thus, a noninvasive and easier method is required. Acoustic radiation force impulse imaging is an ultrasound-based elastographic method and there are studies in the literature that have demonstrated its efficacy in the prediction of liver fibrosis and portal hypertension and in the assessment of thyroid nodules, prostate lesions, focal liver, and kidney lesions, and kidney fibrosis in transplant patients. 7, 8 When compared with conventional elastography, ARFI elastography is advantageous, as it can give an absolute velocimetric value about a specific area of the tissue. 5 Another advantage of the technique is the fact that it does not need external compression. Unlike other organs, a great number of factors have been reported to influence the ARFI examination of the kidney. Factors about kidney heterogeneity or anisotropy such as the pressure applied on the transducer, the location of the sampling area to the pyramidal axis, and the cortical or medullar location of an ROI have been reported to have an influence on ARFI measurements. 5 Thus, pathologies that influence a complex organ such as the kidney may not be explained with the changes in only one or a few parameters. The kidney is an organ with a rich perfusion that takes 25% of the cardiac output and renal perfusion pressure, blood flow, and filtrate volume, and urine pressure may show variations and may influence the SW values and may even hide the pathologies. 5 A standard measurement is required to minimize the influence of all these variables in ARFI measurements. Acceptable interobserver agreement was achieved with the standard procedure we created in our study.
There are few studies in the literature that are conducted wholly on adults about the use of ARFI imaging as a noninvasive method for staging the renal fibrosis or disease of patients with CKD. There are also no available studies in the literature about the use of ARFI in pediatric CKD patients. In studies conducted on adults with CKD, the ARFI and SW values were found to decrease as the level of renal fibrosis increased. 3, 5, 9 In this study, the SW values were lower in all stages in pediatric patients with CKD when compared with the healthy volunteers. In a study by Guo et al, ARFI imaging could not predict any of the CKD stages except stage 5.
3 Similarly, in pediatric patients with CKD, ARFI was unable to distinguish stages 1, 2, 3, and 4 from each other, whereas in the current study, it was able to distinguish stage 5 from these four stages. In our study, stages 1, 2, 3, and 4 were addressed as a predialysis group, and their SW values were found to be statistically higher than those of stage 5 (ie, the dialysis patient group). The reason why ARFI imaging cannot distinguish between CKD stages may be the fact that similar features such as glomerulosclerosis, tubular atrophy, and interstitial fibrosis can be seen in different CKD stages pathologically, and these features overlap in different stages. 4 Further studies can be conducted to confirm this hypothesis; however, the aforementioned limitations in kidney ARFI measurements should be kept in mind. In our study, a threshold value of 1.32 distinguishes between predialysis and dialysis groups, and 1.81 distinguishes between healthy volunteers and CKD patients. According to these results, ARFI imaging can be used instead of the biopsy method, which is an invasive procedure for distinguishing CKD patients from healthy individuals. In addition, our study shows that predialysis and dialysis patient groups can be distinguished from each other with ARFI imaging.
One limitation of our study was the relatively small patient group, and another limitation was that the effects of potentially influencing factors (ie, age, gender, body mass index, blood pressure, kidney perfusion) on SW measurements were not studied. Further studies are needed on these factors.
In conclusion, ARFI imaging is an effective tool that can be used as a radiation-free imaging modality in the early diagnosis and noninvasive assessments of pediatric CKD patients.
